Načítá se...
HDAC10 as a potential therapeutic target in ovarian cancer
OBJECTIVE: We analyzed histone deacetylase 10 (HDAC10) for function in the context of the DNA damage response in BRCA1-null ovarian cancer cells as well as evaluated the potential of general HDAC inhibitors in primary ovarian carcinoma cells. HDAC10 had previously been shown to be highly stimulatory...
Uloženo v:
| Vydáno v: | Gynecol Oncol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6020686/ https://ncbi.nlm.nih.gov/pubmed/28073598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2017.01.009 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|